当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Cellular & Molecular Immunology杂志
Cellular & Molecular Immunology
基本信息
期刊名称 Cellular & Molecular Immunology
CELL MOL IMMUNOL
期刊ISSN 1672-7681
期刊官方网站 https://www.nature.com/cmi
是否OA No
出版商 Springer Nature
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 2008
年文章数 100
影响因子 21.8(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 IMMUNOLOGY 免疫学1区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 5.23 2.728 1.657
Medicine
Infectious Diseases
14 / 272 95%
Medicine
Immunology and Allergy
25 / 188 86%
Immunology and Microbiology
Immunology
32 / 198 84%
补充信息
自引率 1.4%
H-index 64
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1672-7681%5BISSN%5D
投稿指南
期刊投稿网址 https://mts-cmi.nature.com/
收稿范围
Cellular & Molecular Immunology is a monthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, Cellular & Molecular Immunology provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo.

The journal publishes Articles, Review Articles, Mini Reviews and Short Communications and Correspondences in all areas of cellular and molecular immunology, including but not limited to:

    clinical immunology
    comparative immunology
    immunobiology
    immunogenetics
    immunological techniques
    immunopathology
    immunopharmacology
    infection immunology
    neuroimmunology
    transplantation immunology
    tumor immunology
    veterinary immunology

As China's first English-language immunology journal, Cellular & Molecular Immunology is designed to serve both the Chinese and international communities as a vehicle to rapidly disseminate the latest studies in this field. The journal welcomes submissions that explore novel ideas or un- or contra-orthodox approaches, as long as they are underpinned by conventional scientific practice and present falsifiable hypotheses that are tested with empirical methods and evidence.

Manuscripts must provide evidence that can be critically evaluated, and where applicable:

    define disorders and clinical symptoms by standard clinical terms (e.g. allergy, asthma, lupus, etc.)
    deem results 'significant' only using standard statistical methods in biological effects/outcomes studies
    use consistent and defined amounts and mixtures of herbal formulas, or use purified monomer extracts.

Terms that may be ambiguous to the broad audience of the journal should be clearly defined within the manuscript.
收录体裁
Articles
Reviews Articles 
Research Highlights 
Editorials
Correspondence
News and Views
投稿指南 https://www.nature.com/cmi/authors-and-referees
投稿模板
参考文献格式 https://endnote.com/downloads/styles/
编辑信息
Editor-in-Chief
Xuetao Cao, Beijing
Zhigang Tian, Hefei
Associate Editors
M. Eric Gershwin, Davis
Bin Gao, Bethesda
Liwei Lu, Hongkong
Antonio Bertoletti, Singapore
Stipan Jonjic, Rijeka
Weiping Zou, Michigan
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug